in ,

Capricor Receives DoD Grant to Develop Therapeutic Exosome Production Process

Capricor Receives DoD Grant to Develop Therapeutic Exosome Production Process - top government contractors - best government contracting event

healthcareThe Defense Department has awarded Capricor Therapeutics a $2.4 million grant to develop a process to produce cardiosphere-derived cell exosomes.

Capricor said Monday it plans to file an investigational new drug application with the Food and Drug Administration in 2017 for the use of CAP-2003 to treat ocular graft-versus-host disease.

“As we advance and expand our exosomes program, this grant from the DoD will support our objective of achieving a commercial manufacturing process for a candidate which we believe has broad treatment potential,” said Linda Marban, Capricor president and CEO.

“As a cell-free material, CAP-2003 can be handled and stored in similar fashion to a traditional biopharmaceutical,” Marban added.

CAP-2003 vesicles have been isolated from Capricor’s proprietary cardiosphere-derived cells, which the company currently evaluates as a potential treatment for heart diseases associated with Duchenne muscular dystrophy.

ExecutiveBiz Logo

Sign Up Now! ExecutiveBiz provides you with Daily Updates and News Briefings about Healthcare IT

mm

Written by Dominique Stump

Premier Survey: Health System Leaders Begin Strategies for Potential Zika Outbreak - top government contractors - best government contracting event
Premier Survey: Health System Leaders Begin Strategies for Potential Zika Outbreak
Grant Thornton: Gov't CIOs Face Challenges in IT Workforce, Management, Processes - top government contractors - best government contracting event
Grant Thornton: Gov’t CIOs Face Challenges in IT Workforce, Management, Processes